Delphyr logo — Delphyr is a medical data platform that unlocks patient-leve...

Delphyr

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.

Founded 2023 The Netherlands The Netherlands 14 employees Total: $2.03M AI, Health Care +1

General Information

Company Name Delphyr
Founded Year 2023
Location The Netherlands The Netherlands
Employees 14
Industries AI, Health Care, Healthtech
Business Model B2B, SaaS, Platform
Revenue Model Subscription, Usage Based, Service Fee
Offices as of Sep 2026
Amsterdam, The Netherlands
Social

BounceWatch is an independent company data service, not affiliated with Delphyr. To contact Delphyr, visit delphyr.ai.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Delphyr compare?

A PDF of Delphyr and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Delphyr soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

Homepage Update

Significant changes detected on company website (57.1% content change).

In The News Sep 27, 2026

Featured on Health Tech World: Dutch startup Delphyr raises €1.75 million

Feature Release Sep 09, 2026

Delphyr has launched Search & Summarize, a new AI-driven capability for its platform that provides source-linked summaries from patient records within existing EHRs.

About Delphyr

Delphyr, founded in 2023, is an AI-driven platform poised to revolutionize healthcare analytics. As a pioneer in the AI and Healthtech sectors, the company is based in The Netherlands.

With the slogan, "Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians," the platform is designed to streamline data analytics, optimizing time management for healthcare professionals while enhancing patient outcomes and minimizing hospital expenditures.

Delphyr recently secured a €1.75M angel investment on 01 March 2026, with backing from notable investors such as Gijs Nagel and Thomas Wolf. This funding milestone underscores strong confidence in Delphyr's vision and potential for transformative impact in medical data processing.

The company's cutting-edge technology positions it strategically at the intersection of healthcare and artificial intelligence, making it an attractive opportunity for further investment and growth within these dynamic industries.

Taxonomy: Medical Data Platform, Patient-Level Data Analytics, AI-Driven Technology, Clinical Decision Support, Digital Health, Healthcare Efficiency, Outcome Improvement, Cost Reduction, Machine Learning in Medicine, Advanced Medical Statistics, Surgery Analytics, Anesthesiology Data, Internal Medicine Analytics

Services & Products

AI-powered clinical workflow integration
Automated patient information management
EHR extension and optimization
Summarization of medical data
Compliance with healthcare regulations

Target Customers

Healthcare professionals Hospitals Primary care physicians Mental health clinics General practitioners

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Angel €1.75M 2
Gijs Nagel, Thomas Wolf
01 Mar 2026
Angel €280.00K 1
Innovatiefonds Noord-Holland
01 Dec 2024

Delphyr Alternatives & Competitors

View All Alternatives
Delphyr vs
Deep Breath 🫁
Deep Breath 🫁 The Netherlands

Better ICU care is here. Just ask the data.

Seed
8 employees
AI, Health Care
Delphyr vs
Aevus Precision Rx
Aevus Precision Rx United States

Machine-Learning powered prescription guidance for Type 2 Diabetes

2-10 employees
AI, Biotechnology
Delphyr vs

Unlocking power of clinical data.

Seed
15 employees
AI, Analytics

FAQ About Delphyr

Delphyr is a medical data platform that unlocks patient-level data analytics for busy clinicians.
Delphyr was founded in 2023.
Delphyr is headquartered in The Netherlands. As of Sep 2026, it also has offices in Amsterdam, The Netherlands.
Delphyr operates in AI, Health Care and Healthtech. Its work centres on Medical Data Platform, Patient-Level Data Analytics, AI-Driven Technology and Clinical Decision Support. Its customers include Healthcare professionals, Hospitals and Primary care physicians.
Delphyr has a B2B, SaaS and Platform business model. Its revenue comes from Subscription, Usage Based and Service Fee.
Delphyr has approximately 14 employees.
Delphyr has completed 2 funding rounds, raising a total of $2.03M.
Delphyr offers: AI-powered clinical workflow integration, Automated patient information management, EHR extension and optimization, Summarization of medical data, Compliance with healthcare regulations.
Top alternatives and competitors to Delphyr include Deep Breath 🫁, Aevus Precision Rx, CliniNote - unlocking clinical data, DX Medical Solutions, AiCure. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Delphyr and Deep Breath 🫁 are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Delphyr, https://bouncewatch.com/company/delphyr, updated 20 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes